Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
N. Scott Fine currently holds 266,354 shares of Cyclo Therapeutics, Inc. (CYTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, N. Scott Fine has been a net buyer of CYTH stock. They have purchased $683.4K and sold $221.3K worth of shares.
N. Scott Fine's most recent insider trade was on Jun 3, 2024, when they sold 266,354 shares at $0.00 per share.
N. Scott Fine serves as Executive at Cyclo Therapeutics, Inc. (CYTH). They have executed 34 insider transactions totaling $904.7K over their tenure at the company.
N. Scott Fine holds the position of Executive at Cyclo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
N. Scott Fine has shown a buying trading pattern, with $683.4K in total purchases and $221.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by N. Scott Fine was on Feb 19, 2014, when they purchased $225.0K worth of CTDH shares. This transaction involved 4,500,000 shares at $0.05 per share.
N. Scott Fine currently owns 266,354 shares of Cyclo Therapeutics, Inc. (CYTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of N. Scott Fine's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. N. Scott Fine has 34 Form 4 filings on record as an insider at Cyclo Therapeutics, Inc..
Set alerts for N. Scott Fine and 40,000+ other insiders.